Oxytocin

Oxytocin is a peptide (specifically a nonapeptide). It is a hormone and neurotransmitter consisting of a chain of nine amino acids that is produced in the hypothalamus and released by the posterior pituitary gland to act on various organs, including the uterus and breasts.

Key Benefits of Using Oxytocin

• May support muscle recovery and tissue healing
• Commonly studied for its role in pain reduction and inflammation support
• May help improve sexual health and reproductive function
• Research suggests potential benefits for wound healing and gastrointestinal function

FDA-Approved Uses of Oxytocin

“FDA-approved for obstetric use in antepartum and postpartum settings. NOT approved for psychological or behavioral conditions (e.g., autism, social bonding) — those uses are off-label and investigational.

Antepartum (Before/During Labor):

1. Induction of labor: Initiation of uterine contractions when medically indicated — maternal diabetes, preeclampsia, premature rupture of membranes, post-term pregnancy.
2. Stimulation/augmentation of labor: When labor is progressing inadequately.
3. Management of incomplete, inevitable, or elective abortion (second trimester).

Postpartum:

4. Control of postpartum hemorrhage: Stimulate uterine contractions after delivery to reduce blood loss.
5. Treatment of postpartum uterine atony: Promote uterine tone following placental delivery.”

Trade Names of Oxytocin in USA and Manufacturers

• Generic oxytocin injection (10 USP units/mL) — currently manufactured by Fresenius Kabi USA, LLC and other generic manufacturers.
• Syntocinon (oxytocin injection) — brand name DISCONTINUED in US market.
• Oxytocin is widely available as a generic injectable. Multiple manufacturers supply the hospital market.

Note: OTC intranasal oxytocin sprays marketed for non-obstetric uses (e.g., social bonding, weight loss) are NOT FDA-approved for any indication.”

Dosage of Oxytocin

Administered by healthcare professionals in clinical/hospital settings only.
Not a self-administered outpatient medication for approved indications.

Induction or Stimulation of Labor (IV infusion — diluted solution):
Initial rate: 0.5–1 milliunits/min IV (continuous pump infusion)
Titration: Increase by 1–2 milliunits/min every 30–60 minutes
Usual range: 1–20 milliunits/min
Maximum: Generally ≤20–40 milliunits/min
[Titrated based on uterine contraction frequency/duration and fetal heart rate. Continuous fetal monitoring required.]

Control of Postpartum Hemorrhage:
IV infusion: 10–40 units in 1,000 mL isotonic saline at rate to sustain uterine contraction
IM injection: 10 units after placental delivery

Second-Trimester Abortion:
IV infusion: 10–20 milliunits/min

Dosage form: Injection solution, 10 USP Oxytocin units/mL (1 mL and 30 mL vials)

Pricing of Oxytocin

Hospital-administered drug; patients do not purchase directly. Costs are included in hospital billing.

Approximate institutional/wholesale vial costs:
1 mL vial (10 units): ~$10–$40/vial
30 mL multidose vial: ~$25–$80/vial
[Final patient cost depends on hospital billing and insurance]

Compounded intranasal oxytocin (off-label, not FDA-approved): ~$30–$100/bottle from compounding pharmacies.

Coverage by Insurance Type

When administered in hospital setting for FDA-approved obstetric indications:

1. ACA Marketplace: Covered as part of labor and delivery services
2. Employer Insurance: Covered as part of labor and delivery services
3. Medicare Part B: Covered when administered under a covered procedure
4. Medicaid: Covered for medically necessary obstetric use in all states
5. TRICARE (Military): Covered for obstetric indications

Compounded intranasal oxytocin (off-label): Generally NOT covered

Tips

– Oxytocin for labor induction is hospital-administered; patients do not source or purchase it independently.
– Inform obstetric team of all medications — prostaglandins and vasoconstrictors can interact with oxytocin.
– Do not use unregulated non-prescription oxytocin nasal sprays marketed for weight loss, social bonding, or autism — not FDA-approved; safety and efficacy not established.
– Continuous fetal monitoring is standard during IV oxytocin infusion for labor induction.
– Excess oxytocin can cause uterine hyperstimulation or fetal distress — dose titration by trained clinical staff is essential.

Side Effects of Oxytocin

Maternal:
– Uterine hyperstimulation, hypertonic contractions, uterine spasm, or uterine rupture (with excessive dosing or hypersensitivity).
– Nausea and vomiting.
– Postpartum hemorrhage (with inadequate uterine tone).
– Cardiac arrhythmias including sinus bradycardia and abnormal AV rhythms (with certain anesthetic agents).
– Severe hypotension or hypertension: Severe hypertension reported when oxytocin given 3–4 hours after vasopressor use with caudal block anesthesia.
– Water intoxication with convulsions and coma: With slow prolonged IV infusion over 24 hours (antidiuretic effect); maternal deaths reported.
– Afibrinogenemia and increased blood loss (excessive dosing).
– Anaphylaxis (rare).

Fetal/Neonatal (secondary to uterine hyperstimulation):
– Fetal bradycardia and non-reassuring heart rate patterns.
– Fetal hypoxia.
– Low Apgar scores, neonatal seizures, neonatal jaundice.

Contraindications

Per FDA prescribing information:
– Significant cephalopelvic disproportion.
– Unfavorable fetal positions not correctable before delivery.
– Obstetric emergencies where surgical intervention is preferred.
– Fetal distress when delivery is not imminent.
– Prolonged use in severe uterine inertia or severe toxemia.
– Situations where vaginal delivery is contraindicated (active genital herpes, cord prolapse, placenta previa, vasa previa).
– Known hypersensitivity to oxytocin.
– Cyclopropane anesthesia (may cause unexpected cardiovascular effects).
– Not for first-trimester use (except in abortion indications).

Pharmacology

Oxytocin is a synthetic nonapeptide (9 amino acids) identical in structure to the naturally occurring hormone produced in the hypothalamus and released by the posterior pituitary gland. Chemical designation: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂ with a disulfide bridge between positions 1 and 6. MW ~1,007 daltons. Provided as sterile aqueous solution for injection (10 USP units/mL, pH 3.0–5.0). Plasma half-life ~1–6 minutes — necessitating continuous IV infusion for labor management. Metabolized by oxytocinase enzymes in plasma and liver; cleared renally.

Mechanism of action

Oxytocin binds to G-protein coupled oxytocin receptors (OTR) on uterine smooth muscle cells (myometrium) and mammary gland myoepithelial cells.

Binding activates Gq/11 signaling → increases intracellular IP3 and DAG → elevates intracellular calcium → triggers smooth muscle contraction.

Key regulatory features:
– Uterine sensitivity increases significantly near term and during labor (estrogen increases OTR expression; progesterone decreases it).
– Mild antidiuretic effect (structural homology to vasopressin) — explains water intoxication risk with prolonged high-dose infusions in hypotonic fluids.
– Postpartum: sustained uterine contractions compress uterine vasculature and reduce blood loss.

Result Claims from Different Companies

Fresenius Kabi USA (generic) and historical Pitocin brand (Pfizer/King):
– Oxytocin injection has been a clinical standard for labor induction and postpartum hemorrhage management since the 1950s; efficacy in stimulating uterine contractions is well-established through decades of clinical use and guideline support.
– No contemporary marketing claims are made in the same manner as newer branded medications — efficacy is established by extensive obstetric clinical evidence.
– The WHO lists oxytocin injection on its Essential Medicines List for postpartum hemorrhage control.
– ACOG (American College of Obstetricians and Gynecologists) endorses oxytocin as first-line for labor induction and postpartum hemorrhage management in its clinical guidelines.

Disclaimer

This content about “Oxytocin” is for informational and educational purposes only, is not medical advice, does not replace consultation with a licensed healthcare professional, and affiliate links may result in compensation at no additional cost to you.